Gordon J. Macdonald

Effects of TCDD-estradiol interactions in three strains of mice

Interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and estradiol were studied in three strains of mice: CD-1 and C57B/6 (TCDD sensitive) and DBA/2 (TCDD resistant at lower doses). Immature females were injected with 0-200 ng/kg/day estradiol for 2 weeks, s.c. On days 7, 9, 11, and 13, mice received 10 micrograms TCDD/kg by gavage. Relative uterine weight increased in mice of all three strains treated with estradiol alone. Uterine imbibition was suppressed by TCDD treatment, although this effect was antagonized in a saturable manner by coadministration of estradiol. TCDD induced aryl hydrocarbon hydroxylase (AHH) in liver microsomes of treated mice independent of estradiol dose and strain of mice (the dose of TCDD used was high enough to cause AHH induction in the resistant DBA/2 mice). Treatment of CD-1 mice, but not other strains, with TCDD and estradiol resulted in a decrease in the electrophoretic band of hepatic microsomal proteins comigrating with cytochrome P-450a and epoxide hydrase.

Steroid control of steroidogenesis in isolated adrenocortical cells: molecular and species specificity

The molecular and species specificity of glucocorticoid suppression of corticosteroidogenesis was investigated in isolated adrenocortical cells. Trypsin-isolated cells from male rat, domestic fowl and bovine adrenal glands were incubated with or without steroidogenic agents and with or without steroids. Glucocorticoids were measured by radioimmunoassay or fluorometric assay after 1-2 h incubation. Glucocorticoids suppressed ACTH-induced steroidogenesis of isolated rat cells with the following relative potencies: corticosterone greater than cortisol = cortisone greater than dexamethasone. The mineralocorticoid, aldosterone did not affect steroidogenesis. Suppression by glucocorticoids was acute (within 1-2 h), and varied directly with the glucocorticoid concentration. Testosterone also suppressed ACTH-induced steroidogenesis. Glucocorticoid-type steroids have equivalent suppressive potencies, thus suggesting that these steroids may induce suppression at least partly by a common mechanism. Although corticosterone caused the greatest suppression, testosterone was more potent. The steroid specificity of suppression of cyclic AMP (cAMP)-induced and ACTH-induced steroidogenesis were similar, suggesting that suppression is not solely the result of interference with ACTH receptor function or the induction of adenylate cyclase activity. Exogenous glucocorticoids also suppressed ACTH-induced steroidogenesis of cells isolated from domestic fowl and beef adrenal glands, thus suggesting that this observed suppression may be a general mechanism of adrenocortical cell autoregulation.

Rat cholesterol side-chain cleavage enzyme (P-450scc): use of a cDNA probe to study the hormonal regulation of P-450scc mRNA levels in ovarian granulosa cells.

A rat ovarian cDNA library was constructed and screened by differential colony hybridization to detect cDNA clones specific for mRNA induced by follicle-stimulating hormone (FSH). The cDNA clone which demonstrated the greatest degree of induction contained a 766-bp insert which was characterized and sequenced. We conclude that this cDNA is specific for the rat gene coding for cholesterol side-chain cleavage enzyme (P-450scc) by virtue of nucleotide sequence homology to the bovine and human P-450scc cDNA sequences. Southern blotting of rat genomic DNA suggests the presence of a single P-450scc gene. Northern blot analysis indicates that P-450scc mRNA is present in steroidogenic tissues (ovary, adrenal, testis), but not in brain, kidney, liver, lung, or heart. The rat P-450scc mRNA is induced by FSH or pregnant mares serum gonadotropin in ovaries of estrogen-treated immature rats in vivo. In cultured granulosa cells, estradiol treatment alone did not increase P-450scc mRNA levels, but in combination with FSH or 8-Br-cAMP resulted in three- to four-fold increase in this mRNA.

Neonatal Transection Alters the Percentage of Substance-P-Positive Trigeminal Ganglion Cells That Contribute Axons to the Regenerate Infraorbital Nerve

Neonatal transection results in a marked reduction of the number of trigeminal (V) ganglion cells that contribute axons to the regenerate infraorbital nerve (ION; Jacquin and Rhoades, 1985; Chiaia et al., 1987). Such lesions also produce a profound deafferentation of the V brain stem complex that appears to spare the innervation of layers I and II of subnucleus caudalis (SpC) by substance-P-positive (SP-positive) primary afferents (Jacquin and Rhoades, 1985; Rhoades et al., 1988). In the present study, we combined retrograde tracing with immunocytochemistry to determine whether neonatal transection of the ION alters the percentage of SP-positive V ganglion cells that contribute axons to this V branch upon regeneration. In V ganglia ipsilateral to the intact ION (n = 8), 11.6% +/- 3.2% of the cells labeled after application of true blue (TB) to the ION were also SP-positive. In ganglia ipsilateral to the neonatally damaged nerve (n = 8), 18.6% +/- 4.7% of the cells labeled after application of TB to the regenerate ION were also SP-positive (p less than 0.001). We also compared the SP content of intact ganglia (n = 10) with that of ganglia ipsilateral to the damaged nerve (n = 10) by means of radioimmunoassay. The normal V ganglia contained (mean +/- SD) 3496 +/- 774 pg SP/mg protein. The value for the ganglia ipsilateral to the damaged nerve was 5533 +/- 1746 pg SP/mg protein (p less than 0.01). There was no significant difference between SP levels on the control and partially deafferented sides of the brain stem in neonatally nerve-damaged adult rats. In one additional experiment, we injected TB into both vibrissa pads of seven rats on the day of birth prior to transection of the ION. After an 8-hr delay, the nerve on one side was then cut and allowed to regenerate, and both V ganglia were then processed for immunocytochemistry. On the nerve-damage side, 25.8% of the TB-labeled cells were SP-positive. The value for the intact side was 12.0% (p less than 0.000001). This result demonstrated that the lesion-induced change in the percentage of SP-positive ION cells was not the result of either late-growing axons from SP-positive ganglion cells that may have been missed by our nerve cuts or collateral sprouting into the regenerate ION by undamaged SP-positive ganglion cells.

Partial Restoration Of Lutropin Activity by an Intersubunit Disulfide Bond: Implications For Structure/Function Studies

Gonadal function is controlled by lutropins and follitropins, heterodimeric cystine knot proteins that have nearly identical α-subunits. These heterodimeric proteins are stabilized by a portion of the hormone-specific β-subunit termed the “seatbelt” that is wrapped around α-subunit loop 2 (α2). Here we show that replacing human chorionic gonadotropin (hCG) α2 residue Lys51 with cysteine or alanine nearly abolished its lutropin activity, an observation that implies that αLys51 has a key role in hormone activity. The activity of the heterodimer containing αK51C, but not that containing αK51 A, was increased substantially when β-subunit seatbelt residue pAsp99 was converted to cysteine. As had been reported by others, heterodimers containing αK51C and βD99C were crosslinked by a disulfide. The finding that an intersubunit disulfide restored some of the activity lost by replacing αLys51 suggests that this residue is not crucial for receptor binding or signaling and also that hCG and related hormones may be particularly sensitive to mutations that alter interactions between their subunits. We propose the unique structures of hCG and related family members may permit some subunit movement in the heterodimer, making it difficult to deduce key residues involved in receptor contacts simply by correlating the activities of hormone analogs with their amino acid sequences.

Maintenance of Pregnancy in the Rat in the Absence of LH

Summary Pregnant rats were hypophysectomized and pituitary autografted on day 2, the day after sperm were observed in the vaginal lavage. Estradiol-17β (E-17-β) was injected (0.1 μg/day) on days 8 through 16 to induce implantation and maintain pregnancy. This protocol resulted in a 4 day delay of implantation, and day 8 becomes equivalent to day 4 of normal pregnancy. A single dose of LHAS (equivalent to 1.4 times the dose necessary to cause abortion on day 8 in the normal pregnant rat) failed to prevent implantation when administered on day 7 or cause fetal resorption when administered on days 11, 12, 13, 14 or 15 (equivalent to days 4, and 7 through 11). LHAS given on the two successive days 13 and 14 (days 9 and 10 equivalent) was also without effect. These results suggest that LHAS causes abortion in the rat by acting on pituitary LH-like material and not on the ovary, developing fetus or placenta.